Deciphering the role of exosomes in tuberculosis. Issue 1 (January 2015)

• Record Type: Journal Article
• Authors: Kruh-Garcia, Nicole A.; Wolfe, Lisa M.; Dobos, Karen M.
• Is Part Of: Tuberculosis. Volume 95:Issue 1(2015)
• Page Start: 26
• Page End: 30
• Publication Date: 2015-01
• Subjects: Biomarkers -- Mass spectrometry -- Exosomes -- Proteomics; 616.995
• DOI: 10.1016/j.tube.2014.10.010
• Languages: English
• ISSNs: 1472-9792

Abstract

Summary: Exosomes were originally described as small vesicles released from reticulocytes during the maturation process. These 40–200 nm microvesicles were hypothesized to be a mechanism for the removal of membrane proteins in lieu of intracellular degradation by Harding et al. (1984) and Johnstone et al. (1987) [1, 2]. Exosomes can be distinguished from other extracellular vesicles (ectosomes, apoptotic blebs) based on their size and the protein indicators intercalated in their membrane (also, linking their derivation from the endocytic pathway) by Simpson (2012) [3]. The exact role which exosomes play in cell-to-cell communication and immune modulation is a topic of intense study. However, the focus of most reports has been directed towards discovering aberrations in exosomal protein and RNA content linked to disease onset and progression, and also primarily related to cancer. Nonetheless, exosomes are now documented to be released from a wide variety of cell types by Mathivanan et al. (2012), Simpson et al. (2012) and Kalra et al. (2012) [4–6] and have been isolated from all bodily fluids; thus, exosomes are an excellent source of biomarkers. Here we describe the discoveries related to the role exosomes play in tuberculosis disease, as well as translational work in vaccine development and how circulation of these dynamic vesicles can be harnessed for diagnostic purposes.